ANDREEA MAGHIAR: Open Payments
NPI 1891535878 · STONY BROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 24 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $662 · 2025 $1,314
Food & beverage: $1,314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $576 |
| Madrigal Pharmaceuticals | 2 | $290 |
| Janssen Biotech, Inc. | 3 | $190 |
| Gilead Sciences, Inc. | 1 | $130 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $108 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, LINZESS, Livdelzi, SKYRIZI, MAVYRET, XIFAXAN.
Industry payments across NY — which companies pay providers there.
